Menu Search
Equities

scPharmaceuticals Inc

2SX:BER

scPharmaceuticals Inc

Actions
  • Price (EUR)3.92
  • Today's Change-0.10 / -2.49%
  • Shares traded--
  • 1 Year change-18.33%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at scPharmaceuticals Inc fell by 24.43m. However, Cash Flow from Investing totalled 19.97m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 59.24m for operations while cash generated from financing totalled 14.85m.
Cash flow per share-1.56
Price/Cash flow per share--
Book value per share0.256
Tangible book value per share0.256
More ▼

Balance sheet in USDView more

scPharmaceuticals Inc has a Debt to Total Capital ratio of 81.21%, a higher figure than the previous year's 59.50%.
Current ratio4.84
Quick ratio3.66
Total debt/total equity4.32
Total debt/total capital0.8121
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.